Home > Insider Trading > Filing (0001415889-25-010536)

Filing Details

Accession Number:: 0001415889-25-010536
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-04-10 16:12:22
Reporting Period:: 2025-04-09

Filing Date:: 2025-04-10
Accepted Time:: 2025-04-10 16:12:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1818331	Genedx Holdings Corp.	WGS	Services-Health Services (8000)	851966622

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1944119	Kevin Feeley	C/O Genedx Holdings Corp. 333 Ludlow St, North Tower, 6Th Floor Stamford CT 06902	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2025-04-09	1,246	$32.67	17,242	No	4	M	Direct
Class A Common Stock	Disposition	2025-04-09	637	$83.67	16,605	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	1,198	$84.61	15,407	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	1,171	$85.73	14,236	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	249	$86.48	13,987	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	6,810	$93.26	7,177	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	3,122	$94.60	4,055	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	1,463	$95.53	2,592	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	846	$96.46	1,746	No	4	S	Direct
Class A Common Stock	Disposition	2025-04-09	20	$97.26	1,726	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2025-04-09	1,246	$0.00	1,246	$32.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,473		2032-08-31	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.07 to $84.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.13 to $84.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.25 to $86.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.04 to $96.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.07 to $96.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date